NEOSPHERE
LIVE

Serial Number

97489090

Owner

NEOsphere Biotechnologies GmbH

Attorney

Leo M. Loughlin

Filing Date

Jul 5, 2022

Add to watchlist:

No watchlists yet
View on USPTO

NEOSPHERE Trademark

Serial Number: 97489090 • Registration: 7989273

NEOSPHERE is a trademark filed by NEOsphere Biotechnologies GmbH on July 5, 2022. The trademark is classified under Class 42 (Computer & Scientific). The application is currently registered and active.

Owner Contact Info

NEOsphere Biotechnologies GmbH

Planegg 82152 , DE

Entity Type: 16

Trademark Details

Filing Date

July 5, 2022

Registration Date

October 21, 2025

Published for Opposition

September 2, 2025

Goods & Services

Analysis in the field of molecular biology; Consultancy relating to pharmaceutical research and development; Consultancy in the field of pharmaceutical research; Pharmaceutical product evaluation; Biochemistry research services; Biochemical analysis; Biochemistry services in the nature of mass spectrometry based proteomics and proteomic data analysis; Biochemical research and analysis; Biological analysis; Biological research and development services; Biological research; Biological research and analysis; Biological research, clinical research and medical research; Biomedical research services; Biotechnological research relating to industry; Research relating to biotechnology; Computer programming in the medical field; Computer software programming services; Medical research laboratory services; Biological research laboratory services; Services for assessing the efficiency of pharmaceuticals being testing of pharmaceuticals; Biotechnology testing; Analysis of human serum for medical research; Analysis of human tissues for medical research; Conducting of scientific studies and research in the field of targeted protein degradation and targeted protein stabilization and related data analysis; Development of pharmaceutical drug preparations and medicines; Development and creation of computer programmes for data processing; Computer software development for others; Development of data bases; Pharmaceutical products development; computer software development; Design and development of data processing programs; Research and development of vaccines and medicines; Research relating to molecular sciences; Research on the subject of pharmaceuticals; Research and development services in the field of immunology; Research and development in the pharmaceutical and biotechnology fields; Biochemical research and development; Research and development for the pharmaceutical industry; Research and development in the field of microorganisms and cells; Clinical research in the field of targeted protein degradation and targeted protein stabilization and related data analysis; Medical and scientific research, namely, conducting clinical trials for others; Laboratory research services relating to pharmaceuticals; Medical research; Medical research in the field of oncology; Pharmaceutical drug development services; Pharmaceutical research services; Pharmaceutical research and development; Preparation of biological samples for research purposes; Preparation of biological samples for analysis in research laboratories; Preparation of biological samples for testing and analysis in research laboratories; Scientific and technological services, namely, scientific analysis in the field of targeted protein degradation and targeted protein stabilization and related data analysis; Scientific research in the field of drug discovery; Scientific research relating to biology; Scientific research and development; Scientific research for medical purposes in the area of cancerous diseases; Scientific investigations for medical purposes

Filing History

NOTICE OF REGISTRATION CONFIRMATION EMAILED
Oct 21, 2025 NRCC
REGISTERED-PRINCIPAL REGISTER
Oct 21, 2025 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Sep 2, 2025 NPUB
PUBLISHED FOR OPPOSITION
Sep 2, 2025 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Aug 27, 2025 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Jul 28, 2025 CNSA
SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
May 21, 2025 RCCK
REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Nov 20, 2024 RCSC
ASSIGNED TO EXAMINER
Aug 30, 2024 DOCK
REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Feb 16, 2024 RCSC
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Aug 16, 2023 GNS3
LETTER OF SUSPENSION E-MAILED
Aug 16, 2023 GNSL
SUSPENSION LETTER WRITTEN
Aug 16, 2023 CNSL
TEAS/EMAIL CORRESPONDENCE ENTERED
Jul 20, 2023 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jul 19, 2023 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jul 19, 2023 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Apr 24, 2023 GNRN
NON-FINAL ACTION E-MAILED
Apr 24, 2023 GNRT
NON-FINAL ACTION WRITTEN
Apr 24, 2023 CNRT
ASSIGNED TO EXAMINER
Apr 19, 2023 DOCK
PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED
Oct 11, 2022 AMPX
ASSIGNED TO LIE
Oct 11, 2022 ALIE
TEAS VOLUNTARY AMENDMENT RECEIVED
Aug 31, 2022 PARI
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jul 25, 2022 NWOS
NEW APPLICATION ENTERED
Jul 8, 2022 NWAP